Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany

News Releases

Merck KGaA, Darmstadt, Germany Divests Biosimilars Business to Fresenius
Merck KGaA, Darmstadt, Germany Divests Biosimilars Business to Fresenius
Darmstadt, Germany, April 24, 2017 – Merck KGaA, Darmstadt, Germany, today announced the divestment of its Biosimilars business to Fresenius. The decision to divest Biosimilars is aligned with the company’s strategy for its Healthcare business sector to focus on its pipeline of innovative medicines.
 
New Paths
New Paths
Immuno-oncology uses the patient’s immune system to attack cancer cells. A promising approach that aims to help more cancer patients in the future.
 
2016 Annual Results
Merck KGaA, Darmstadt, Germany, Generates Record Sales and Continues to Grow Profitably in 2016
Darmstadt, Germany, March 9, 2017 – Merck KGaA, Darmstadt, Germany, finished 2016 with record figures and continued to grow profitably. Sales and earnings rose significantly. Major strategic advances were made in all three business sectors.
 
Please contact media.relations@emdgroup.com for news releases published before 2014.
 
 
 
 
 
 
 
 
 
 
 

DISCLAIMER

Publication of Merck KGaA, Darmstadt, Germany.
There are two different, unaffiliated companies that use the name MERCK. Merck KGaA, Darmstadt, Germany, which operates this website, uses the firm name “Merck KGaA, Darmstadt, Germany,” in the United States and Canada, and also uses “EMD Serono” in biopharma, “MilliporeSigma” in life science and “EMD Performance Materials” in materials business. The other company, Merck & Co., Inc. holds the rights in the trademark MERCK in the United States and Canada. Merck & Co. is not affiliated with or related to Merck KGaA, Darmstadt, Germany, which owns the MERCK trademark in all other countries of the world.   To reflect such fact and to avoid any confusion, certain logos, terms and business descriptions of the publications on this website have been substituted or modified, such as by referring to “Merck KGaA, Darmstadt, Germany” instead of “Merck” standing alone.  Publications on this webpage, therefore, slightly deviate from the otherwise identical versions accessible outside the United States and Canada.
 

FOR MEDIA INQUIRIES, CONTACT

Media Team
POSTAL ADDRESS 
Merck KGaA, Darmstadt, Germany
Frankfurter Straße 250 
64293 Darmstadt 
Germany
Tel.: +49 6151 72-5000
Fax: +49 6151 72-3138
 
Merck KGaA, Darmstadt, Germany on Facebook
Twitter